comparemela.com

Latest Breaking News On - Carll gordon - Page 2 : comparemela.com

Adicet Bio (NASDAQ:ACET) PT Lowered to $26.00 at HC Wainwright

Adicet Bio (NASDAQ:ACET) PT Lowered to $26.00 at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Ohio
United-states
Carll-gordon
Adicet-bio
Jpmorgan-chase-co
Schonfeld-strategic-advisors
Securities-exchange-commission
Tower-research-capital
Sigma-securities
Virtu-financial
Adicet-bio-inc
Free-report

Short Interest in Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Declines By 21.9%

Short Interest in Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Declines By 21.9%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Carll-gordon
Stifel-nicolaus
Jpmorgan-chase-co
American-international-group-inc
Cantor-fitzgerald
Barclays-plc
Securities-exchange-commission
Theseus-pharmaceuticals-stock-performance
News-ratings-for-theseus-pharmaceuticals-daily
Citigroup-inc

Adicet Bio's (ACET) Outperform Rating Reiterated at Wedbush

Wedbush reissued their outperform rating on shares of Adicet Bio (NASDAQ:ACET – Free Report) in a report released on Thursday, Benzinga reports. The firm currently has a $17.00 target price on the stock. A number of other analysts have also weighed in on the company. JPMorgan Chase & Co. lowered Adicet Bio from an overweight […]

Carll-gordon
Adicet-bio
Jump-financial
Securities-exchange-commission
Alpine-global-management
Jpmorgan-chase-co
Adicet-bio-inc
Nasdaq
Carlyle-group-inc
Adicet-bio-company-profile
Free-report
Bio-stock-down

Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Update

Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) saw a significant drop in short interest in July. As of July 31st, there was short interest totalling 2,300,000 shares, a drop of 22.3% from the July 15th total of 2,960,000 shares. Based on an average daily volume of 875,300 shares, the days-to-cover ratio is presently 2.6 […]

Carll-gordon
Adicet-bio
Securities-exchange-commission
Adicet-bio-company-profile
Adicet-bio-inc
Carlyle-group-inc
Jpmorgan-chase-co
Blackrock-inc
Nasdaq
Get-free-report
Bio-trading-down
Director-carl

Theseus Pharmaceuticals (NASDAQ:THRX) Receives "Outperform" Rating from Wedbush

Wedbush reiterated their outperform rating on shares of Theseus Pharmaceuticals (NASDAQ:THRX – Free Report) in a research report sent to investors on Thursday, RTT News reports. The brokerage currently has a $7.00 target price on the stock. Wedbush also issued estimates for Theseus Pharmaceuticals’ Q1 2024 earnings at ($0.33) EPS, Q2 2024 earnings at ($0.35) […]

United-states
American
Carll-gordon
Stifel-nicolaus
American-international-group-inc
Analyst-recommendations-for-theseus-pharmaceuticals
Theseus-pharmaceuticals-inc
Securities-exchange-commission
Theseus-pharmaceuticals-company-profile
Tower-research-capital
Citigroup-inc
Needham-company

vimarsana © 2020. All Rights Reserved.